Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France
Noémie Roland, Jérôme Drouin, David Desplas, François Cuenot, Rosemary Dray‐Spira, Alain Weill, Mahmoud Zureik
Abstract
In Brief Hormonal medication dispensations decreased substantially during lockdown and after in France, especially for emergency contraception, levonorgestrel-releasing intrauterine devices, and ovulation inductors.
Topics & Concepts
LevonorgestrelOvulationCoronavirus disease 2019 (COVID-19)MedicineHormonal contraceptionEmergency contraception2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyFamily planningPopulationHormoneDiseaseInternal medicineInfectious disease (medical specialty)Research methodologyEnvironmental healthOutbreakCOVID-19 Impact on ReproductionReproductive Health and ContraceptionGlobal Maternal and Child Health